Significant Ownership of Mark E. Strome
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Mark E. Strome focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Mark E. Strome - Mark E. Strome
- Manager location
- Santa Monica, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Mark E. Strome and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Mark E. Strome
Significant Ownership of Mark E. Strome
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience, Inc. | Common Stock, par value $.001 per share | 12% | $53,142 | 442,854 | Mark E. Strome | 26 Dec 2024 | ||
| ZIVO | Zivo Bioscience | Common Stock, par value $.001 per share | 12% | 472,942 | Mark E. Strome | 31 Dec 2025 | |||
| CUE | Cue Biopharma, Inc. | Common Stock, $0.001 par value per share | 5% | $1,862,968 | 2,166,242 | Mark E. Strome | 14 Nov 2022 |
Schedules 13D/G Reported by Mark E. Strome:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.